Thiamin and pyridoxine requirements during intravenous hyperalimentation.
Studies were undertaken to determine rational dosages of vitamin B1 and B6 during long-term intravenous hyperalimentation, using more sensitive techniques than formerly used to evaluate B1 and B6 status. A standard vitamin combination, type A, (usually commercially available products) has been used up to now because of convenience, disregarding the effects of long-term administration. This combination lacks biotin, folic acid, and vitamin E and contains from 10 to 100 times the dietary allowances of such vitamins as B1, B2, B6, B12, and C. In response to the possibility of vitamin overdose, two new vitamin combinations, type B (from commercial products) and type C (a convenient and easily administered combination produced at the hospital) were developed in order to provide the normal dietary allowances and at the same time eliminate any harmful side-effects. From the results obtained, 5 mg/day for thiamin HCl and 3 mg/day for pyridoxine HCl in type B and type C were found to be a sufficient and safe level as opposed to 55 mg/day for thiamin HCl and 102 mg/day for pyridoxine HCl in type A.
D000328:Adult; D000368:Aged; D001219:Aspartate Aminotransferases / Q000097:blood; D002675:Child, Preschool; D004796:Clinical Enzyme Tests; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009751:Nutritional Requirements; D010288:Parenteral Nutrition / Q000592:standards*; D010289:Parenteral Nutrition, Total / Q000009:adverse effects / Q000592:standards*; D011736:Pyridoxine / Q000008:administration & dosage* / Q000378:metabolism; D013831:Thiamine / Q000008:administration & dosage* / Q000378:metabolism; D013832:Thiamine Deficiency / Q000175:diagnosis; D013997:Time Factors; D014174:Transketolase / Q000097:blood; D026681:Vitamin B 6 Deficiency / Q000175:diagnosis
D014174:Transketolase; D001219:Aspartate Aminotransferases; D011736:Pyridoxine; D013831:Thiamine